Want to join the conversation?
$USB's BoD has approved a 4-quarter authorization to repurchase up to $2.6Bil of outstanding stock, starting on July 1. This replaces the current 5-quarter authorization which expires on June 30. These capital actions allow the company to achieve its goal to return 60-80% of its earnings to shareholders through dividends and share buybacks.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.